Edition:
United Kingdom

Centene Corp (CNC.N)

CNC.N on New York Stock Exchange

143.71USD
17 Aug 2018
Change (% chg)

$-0.21 (-0.15%)
Prev Close
$143.92
Open
$144.18
Day's High
$144.61
Day's Low
$141.92
Volume
263,250
Avg. Vol
443,258
52-wk High
$145.35
52-wk Low
$82.98

Select another date:

Wed, May 23 2018

BRIEF-Centene Corp Says Unit Issued $1.8 Bln In Aggregate Principal Amount Of 5.375 Pct Senior Notes Due 2026

* CENTENE CORP SAYS UNIT ISSUED $1.8 BILLION IN AGGREGATE PRINCIPAL AMOUNT OF 5.375% SENIOR NOTES DUE 2026 - SEC FILING Source text: (https://bit.ly/2x8KtI9) Further company coverage:

BRIEF-Centene Corp Prices Upsized Offering Of Senior Notes

* CENTENE CORPORATION PRICES UPSIZED OFFERING OF SENIOR NOTES

BRIEF-Centene Corp Announces Offering Of Senior Notes

* CENTENE CORP - UNIT COMMENCED AN OFFERING TO SELL $1.7 BILLION AGGREGATE PRINCIPAL AMOUNT OF SENIOR NOTES DUE 2026

BRIEF-Centene Subsidiary Awarded Contract In Florida

* CENTENE - CO'S FLORIDA UNIT, SUNSHINE HEALTH, HAS BEEN NOTIFIED BY FLORIDA AGENCY FOR HEALTH CARE ADMINISTRATION OF ITS INTENT TO AWARD IT A CONTRACT

BRIEF-Centene Corporation Announces Offering Of Common Stock

* CENTENE CORP - COMMENCED AN OFFERING TO SELL $2.6 BILLION IN SHARES OF COMMON STOCK, PAR VALUE $0.001 PER SHARE

Centene cuts full-year forecast on Fidelis deal delay

Centene Corp on Tuesday cut its full-year forecast due to a delay in closing its $3.75 billion takeover of Fidelis Care, a not-for-profit Medicaid insurer, sending its shares down 3 percent in premarket trading.

UPDATE 2-Centene cuts full-year forecast on Fidelis deal delay

April 24 Centene Corp on Tuesday cut its full-year forecast due to a delay in closing its $3.75 billion takeover of Fidelis Care, a not-for-profit Medicaid insurer, sending its shares down 3 percent in premarket trading.

Health insurer Centene's profit more than doubles

April 24 Centene Corp on Tuesday reported a quarterly profit that more than doubled as it added more members to its health insurance plans.

BRIEF-Centene Corp Reports 2018 Q1 Adj Earnings Per Share $2.17

* ORATION REPORTS 2018 FIRST QUARTER RESULTS AND ADJUSTS 2018 GUIDANCE

BRIEF-Centene Receives Regulatory Approval For Fidelis Care Transaction From New York Department Of Health And New York Department Of Financial Services

* CENTENE RECEIVES REGULATORY APPROVAL FOR THE FIDELIS CARE TRANSACTION FROM NEW YORK DEPARTMENT OF HEALTH AND NEW YORK DEPARTMENT OF FINANCIAL SERVICES Source text for Eikon: Further company coverage:

Select another date: